# PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients

> **NCT01187589** · NA · COMPLETED · sponsor: **Respinova LTD** · enrollment: 15 (estimated)

## Conditions studied

- COPD

## Interventions

- **DEVICE:** Pulsehaler
- **DRUG:** Nebulizer & Albuterol 0.5ml

## Key facts

- **NCT ID:** NCT01187589
- **Lead sponsor:** Respinova LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2011-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01187589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01187589, "PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01187589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*